Khosla Ventures's Biotechnology Portfolio

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

Eat Just is a food technology company that develops plant-based alternatives to egg and meat products.

Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.

Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies.

Color is a healthcare delivery platform that offers cancer prevention, screening programs, and healthcare services for people.

BioConsortia is an agricultural technology company that develops microbial consortia for increasing agricultural yields.

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

Genecis is an early-stage organic waste processing startup that uses biotechnology to convert waste into high-value materials.

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

VitroLabs develops a platform that manufactures real leather using stem cell-based technologies.

Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.

Ultima Genomics is a developer of a low-cost sequencing platform.

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.

Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.

Cellular Intelligence develops AI-driven foundation models and platforms to predict and control cell behavior for regenerative medicine.

Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.

Known Medicine combines patient-specific 3D cell culture and AI to translate drugs to clinical success

Numerion Labs develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer.

Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.

IgGenix is a biotechnology company.

Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.

Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

Vivodyne accelerates drug discovery using lab-grown human tissues, robotics, and AI to generate accurate preclinical test data.

Overture Life is a biotechnology company that develops automated technologies for assisted reproductive procedures.

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology

Synex Medical develops non-invasive blood testing technology.

Inflammatix develops rapid immune system diagnostics to improve patient care and public health.

Earli develops genetic constructs for early cancer detection and targeted therapy.

On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone

Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.

YonedaLabs is an AI-based software that assists chemists in optimizing reaction parameters such as temperature, concentration, and catalyst.

Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.

Probably Genetic helps rare genetic disease patients.

Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

Ukko is a biotechnology company focused on developing immunotherapies for the treatment of allergies and other immune-mediated diseases.

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.

NextVivo is a biotech company developing an immune organoid technology platform.

Opentrons is a life science company that develops pipetting robot technology designed to automate experiments.

Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.

GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Clear Labs is a biotechnology firm that integrates a genomics system to simplify diagnostics for the clinical and application sectors.

Volta Labs develops scalable automation for genetic engineering.

Arpeggio builds technology to watch and learn how drugs work.

Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.

Neurotrack develops digital cognitive health screening solutions to reduce the risk of Alzheimer's and related dementias.

Pearl Bio is a synthetic biology company.

Daye is a gynecological health company that creates products and services for vaginal treatment.

Supplant is a biotechnology platform that makes sugar substitutes.

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

Somite is leveraging data and AI to introduce novel cell replacement therapies.